8 completed, 1 not yet recruiting, 1 recruiting, 1 withdrawn. 11 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 8, Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
Follow Enoplida Infections: new trials by email Literature Review of Enoplida Infections trials Research Report on Enoplida Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita Emodepside, Albendazole 400 mg - Trichuris Infection | Phase 2 | Not yet recruiting | Jennifer Keiser | 100 | 2026-11-15 | 2026-08-14 |
| Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura Oxantel Pamoate, Mebendazole - Trichuris Trichiura; Infection, Hookworm Infection | Phase 2 | Completed | Jennifer Keiser | 163 | 2025-04-16 | 2025-06-08 |
| A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults Albendazole, Oxfendazole - Trichuriasis | Phase 2 | Recruiting | Asociacion Benefica Prisma | 249 | 2024-09-07 | 2026-07-28 |
| Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults Oxfendazole, Albendazole - Trichuris Infection | Phase 2 | Withdrawn | Oxfendazole Development Group | 2024-07-01 | 2026-11-06 | |
| Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC Ivermectin 1.5 mg ODT, Ivermectin 3 mg Oral Tablet, Albendazole 400 mg Oral Tablet - Trichuriasis, Ascariasis | Phase 2 | Completed | Jennifer Keiser | 260 | 2024-06-05 | 2025-09-22 |
| Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm Emodepside - Trichuris Trichiura; Infection, Hookworm Infections | Phase 2 | Completed | Jennifer Keiser | 442 | 2021-08-02 | 2022-05-27 |
| Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration moxidectin (8 mg) / albendazole (400 mg), ivermectin (200 µg/kg) / albendazole (400 mg), ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL] - Trichuriasis, Ascariasis | Phase 2 / Phase 3 | Completed | Jennifer Keiser | 536 | 2021-03-01 | 2024-12-05 |
| Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients Ivermectin, Albendazole - Trichuris Infection, Helminthiasis | Phase 2 | Completed | Alejandro Krolewiecki | 176 | 2019-10-09 | 2020-07-29 |
| Albendazole Dose Finding and Pharmacokinetics in Children and Adults Albendazole, Placebo - Trichuriasis, Hookworm Infections | Phase 2 | Completed | Jennifer Keiser | 700 | 2018-10-23 | 2023-06-12 |
| Efficacy and Safety of IVM/ALB Co-administration Albendazole, Albendazole and Ivermectin - Trichuriasis | Phase 2 / Phase 3 | Completed | Jennifer Keiser | 1673 | 2018-09-09 | 2024-03-20 |
| Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura Moxidectin 8mg, Moxidectin 8 mg + albendazole 400 mg, Moxidectin 16 mg - Trichuris Trichiura; Infection | Phase 2 | Completed | Swiss Tropical & Public Health Institute | 286 | 2018-07-03 | 2018-08-14 |
Trichuriasis (11) · Hookworm Infections (5) · Ancylostomiasis (3) · Ascariasis (2) · Helminthiasis (2) · Intestinal Diseases, Parasitic (1)
Adenophorea Infections (11) · Infections (11) · Nematode Infections (11) · Parasitic Diseases (11) · Helminthiasis (9) · Secernentea Infections (5) · Strongylida Infections (5) · Ascaridida Infections (2) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1)
Albendazole (9) · Ivermectin (4) · Tablets (2) · emodepside (2) · moxidectin (2) · oxfendazole (2) · Mebendazole (1) · oxantel pamoate (1)
Jennifer Keiser (7) · Alejandro Krolewiecki (1) · Asociacion Benefica Prisma (1) · Oxfendazole Development Group (1) · Swiss Tropical & Public Health Institute (1)
Tanzania (6) · Côte d’Ivoire (2) · Argentina (1) · Honduras (1) · Laos (1) · Peru (1)
Alejandro J Krolewiecki, MD, PhD (1) · Jennifer Keiser, PhD (1) · Maribel Paredes Olortegui, MPH (1)
PMID 30885157, PMID 31044235, PMID 32405623, PMID 32668456, PMID 33906234, PMID 34191812, PMID 34632308, PMID 34856181, PMID 35217670, PMID 36354034, PMID 37195942, PMID 37195949, PMID 38517907, PMID 39561184, PMID 40975108, PMID 42486129